December 2025 in “Journal of Dermatological Treatment” GT20029 helps regrow hair in men with hair loss and is well-tolerated.
November 2025 in “Biomedicines” Hypochlorous acid is a safe, effective antimicrobial with potential in various medical fields, but more research is needed to improve its stability and use.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Onion oil may help hair regrowth and scalp health, but more research is needed.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Onion oil may help with hair regrowth and scalp health, but more research is needed.
October 2025 in “World Journal of Advanced Research and Reviews” Onion oil may improve hair health and regrowth.
Most patients were satisfied with topical finasteride, and few experienced side effects.
September 2025 in “Journal of Dermatology Research” Sebamed® shampoo effectively reduces hair loss and promotes hair growth.
September 2025 in “Headache The Journal of Head and Face Pain” The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.
September 2025 in “Dermatologic Surgery” Combining radiofrequency with minoxidil is more effective for hair regrowth in women than using CO2 with minoxidil.
September 2025 in “Asian journal of pediatric dermatology.” Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.
August 2025 in “The American Journal of Medical Sciences and Pharmaceutical Research” Non-injection carboxytherapy is effective and safe for treating problematic skin.
July 2025 in “Annals of Medicine” Gestrinone pellets may help reduce pelvic pain in endometriosis safely.
June 2025 in “Medical alphabet” Fractional lasers, combined with topical therapy, are a promising and safe treatment for hair loss.
April 2025 in “Cytotherapy” UC-MSCs derived secretome therapy may help treat hair loss safely.
April 2025 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” Minoxidil is the most common treatment for male hair loss, but sildenafil shows promise as an alternative.
March 2025 in “Archives of Dermatological Research” Injectable minoxidil may be effective for hair loss but is costly and requires more research.
March 2025 in “Canadian dermatology today.” Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.
January 2025 in “Scholars Journal of Medical Case Reports” Quetiapine may cause hair loss.
January 2025 in “Recent Patents on Anti-Cancer Drug Discovery” The treatment showed high response rates and was well-tolerated, potentially extending patient survival.
Topical GT20029 effectively promotes hair regrowth and is well-tolerated.
January 2025 in “International Journal of Nanomedicine” Rosemary-based gel with metformin may effectively treat hair loss like minoxidil.
December 2024 in “http://isrctn.com/” MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.
October 2024 in “Skin Appendage Disorders” Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.
August 2024 in “Quality in Sport” New treatments for common hair loss are needed.
June 2024 in “Journal of Clinical Oncology” The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.
April 2024 in “Dermatovenerologiâ, kosmetologiâ” Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
March 2024 in “Journal of integral sciences” Rosemary oil may promote hair growth and is a natural alternative to minoxidil.
The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.
February 2024 in “International Journal of Research in Dermatology” Alcohol-free minoxidil 5% is effective and safe for treating male pattern hair loss.
January 2024 in “International Journal of Dermatology Research” Minoxidil alone is as effective as the combination but has fewer side effects.